Exposure to Non-Steroidal Anti-Inflammatory Drugs during Pregnancy and the Risk of Selected Birth Defects: A Prospective Cohort Study

Teratogenic mechanisms of medical drugs

(2010) M. M. H. J. van Gelder et al.   HUMAN REPRODUCTION UPDATE

First trimester diclofenac exposure and pregnancy outcome

(2010) Matteo Cassina et al.   REPRODUCTIVE TOXICOLOGY

Is there epidemiologic evidence to support vascular disruption as a pathogenesis of gastroschisis?

(2009) Martha M. Werler et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART A

Self-selection and bias in a large prospective pregnancy cohort in Norway

(2009) Roy M. Nilsen et al.   PAEDIATRIC AND PERINATAL EPIDEMIOLOGY

What do pregnant women know about non-steroidal anti-inflammatory drugs?

(2009) Christine Damase-Michel et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Registration of Down syndrome in the Medical Birth Registry of Norway: Validity and time trends

(2008) Kari Klungsøyr Melve et al.   ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

Maternal vasoactive exposures, amniotic bands, and terminal transverse limb defects

(2008) Martha M. Werler et al.   BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY

Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106 000 pregnancies in Norway 2004–2006

(2008) Anders Engeland et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY